Cheminformatic Profiling and Hit Prioritization of Natural Products with Activities against Methicillin-Resistant
Anti-Bacterial Agents
/ pharmacology
Anti-Infective Agents
/ pharmacology
Biological Products
/ chemistry
Cheminformatics
/ methods
Databases, Factual
Drug Evaluation, Preclinical
/ methods
Methicillin-Resistant Staphylococcus aureus
/ drug effects
Microbial Sensitivity Tests
Staphylococcus aureus
/ drug effects
Structure-Activity Relationship
cheminformatics
desirability score
drug-likeness
hit-to-lead optimization
methicillin-resistant Staphylococcus aureus (MRSA), hit prioritization
natural products
profiling
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
16 Jun 2021
16 Jun 2021
Historique:
received:
15
03
2021
revised:
28
04
2021
accepted:
08
05
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
14
7
2021
Statut:
epublish
Résumé
Several natural products (NPs) have displayed varying in vitro activities against methicillin-resistant
Identifiants
pubmed: 34208597
pii: molecules26123674
doi: 10.3390/molecules26123674
pmc: PMC8246317
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Anti-Infective Agents
0
Biological Products
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
EXCLI J. 2016 Feb 12;15:113-8
pubmed: 27047321
Pathogens. 2014 Jun 18;3(2):473-98
pubmed: 25437810
J Chem Inf Model. 2018 Mar 26;58(3):550-555
pubmed: 29420025
AAPS J. 2015 Nov;17(6):1327-40
pubmed: 26276218
Br J Pharmacol. 2007 Sep;152(1):9-20
pubmed: 17549047
J Cheminform. 2019 Jan 5;11(1):2
pubmed: 30612223
Br J Pharmacol. 2011 Mar;162(6):1239-49
pubmed: 21091654
J Med Chem. 2009 Apr 9;52(7):1953-62
pubmed: 19265440
Malar J. 2016 Jan 29;15:50
pubmed: 26823078
Brief Bioinform. 2018 Nov 27;19(6):1153-1171
pubmed: 28460068
Front Microbiol. 2019 Oct 31;10:2470
pubmed: 31736910
Medchemcomm. 2018 Nov 30;10(1):148-157
pubmed: 30774861
Biomed Res Int. 2014;2014:305610
pubmed: 24683545
Microb Pathog. 2018 Aug;121:173-178
pubmed: 29775724
Malar J. 2014 Mar 06;13:81
pubmed: 24602358
Microb Pathog. 2018 Jul;120:85-96
pubmed: 29684541
In Silico Pharmacol. 2013 Aug 08;1:12
pubmed: 25505657
Drug Discov Today Technol. 2004 Dec;1(4):337-41
pubmed: 24981612
Chem Cent J. 2018 Sep 20;12(1):97
pubmed: 30238231
J Med Chem. 2002 Jun 6;45(12):2615-23
pubmed: 12036371
Pharmaceutics. 2019 Aug 13;11(8):
pubmed: 31412551
Acta Pharm Sin B. 2018 Sep;8(5):721-732
pubmed: 30245961
Expert Opin Drug Deliv. 2017 Feb;14(2):179-187
pubmed: 27397695
Drug Discov Today. 2016 May;21(5):712-7
pubmed: 26891978
Nat Prod Rep. 2010 Feb;27(2):238-54
pubmed: 20111803
Drug Des Devel Ther. 2018 May 08;12:1147-1156
pubmed: 29780235
Infect Drug Resist. 2018 Oct 10;11:1645-1658
pubmed: 30349322
Nat Rev Drug Discov. 2007 Aug;6(8):636-49
pubmed: 17643090
Expert Opin Drug Discov. 2017 Feb;12(2):115-119
pubmed: 27883294
Sci Rep. 2017 Mar 03;7:42717
pubmed: 28256516
Bioorg Med Chem Lett. 2015 Nov 1;25(21):4802-4807
pubmed: 26254944
Drug Discov Today. 2006 Feb;11(3-4):175-80
pubmed: 16533716
Lancet Infect Dis. 2018 Mar;18(3):318-327
pubmed: 29276051
ChemMedChem. 2016 Jun 6;11(11):1117-21
pubmed: 27218427
J Cheminform. 2018 Aug 10;10(1):36
pubmed: 30097821
J Chem Inf Model. 2015 Feb 23;55(2):460-73
pubmed: 25558886
J Comput Aided Mol Des. 2020 Sep;34(9):929-942
pubmed: 32367387
P T. 2015 Apr;40(4):277-83
pubmed: 25859123
Sci Adv. 2016 Mar 25;2(3):e1501240
pubmed: 27051863
Nat Chem. 2012 Jan 24;4(2):90-8
pubmed: 22270643
Pharmacol Rev. 2013 Dec 31;66(1):334-95
pubmed: 24381236
Expert Opin Drug Discov. 2010 Mar;5(3):235-48
pubmed: 22823020
Med Res Rev. 2016 Jan;36(1):32-91
pubmed: 26359649
Curr Med Chem. 2012;19(21):3605-21
pubmed: 22680629
PLoS Biol. 2019 Mar 27;17(3):e3000202
pubmed: 30917112